🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Cognitive Dysfunction and Delirium After TUR-M in Elderly Patients

Recruitingn/aAges 65 Years - anyAllMuğla Sıtkı Koçman University
NCT07719712 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Elderly patients undergoing transurethral resection are at increased risk of postoperative cognitive dysfunction (POCD) and delirium, which are associated with prolonged hospital stay, increased morbidity, and decreased quality of life. Identifying patients who are more likely to develop postoperative cognitive dysfunction or delirium remains a practical challenge in daily clinical practice. Better recognition of these patients may help tailor perioperative care and improve outcomes. This prospective observational study aims to identify perioperative factors associated with POCD and delirium in elderly patients undergoing transurethral resection and to develop a clinically applicable risk prediction model. Cognitive function and delirium are assessed using the Montreal Cognitive Assessment (MoCA) and the Confusion Assessment Method (CAM). Cognitive function and delirium will be evaluat

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age ≥65 years * Scheduled for transurethral resection procedure * ASA physical status I-III * Able to provide informed consent * Adequate cognitive function to complete preoperative assessment Exclusion Criteria: * Pre-existing diagnosis of dementia or severe cognitive impairment (MoCA \<18) * Severe visual or hearing impairment preventing cognitive assessment * History of psychiatric disease requiring antipsychotic or sedative medication * Neurological disorders associated with increased delirium risk (e.g., Parkinson's disease, epilepsy) * Inability to complete study assessments
💊

What it tests

  • Cognitive and Delirium Assessment (MoCA and CAM)
📍

Where

1 site
Muğla Training and Research Hospital
Muğla, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy